CircAge: A Comprehensive Resource for Aging-associated Circular RNAs Across Species and Tissues
Genomics, Proteomics & Bioinformatics · 2025
DOI: 10.1093/gpbjnl/qzaf044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genomics, Proteomics & Bioinformatics, 2025. Verfasst von Xin Dong und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Genetic Evolution & Animal Models, Key Laboratory of Healthy Aging Research of Yunnan Province, Kunming Institute of Zoology,…. Hauptthemen laut MEDLINE: RNA, Circular, Aging, Databases, Genetic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Circular RNAs (circRNAs) represent a novel class of RNA molecules characterized by a circular structure and enhanced stability. Emerging evidence indicates that circRNAs play pivotal regulatory roles in the aging process. However, a systematic resource that integrates aging-associated circRNA data remains lacking. Therefore, we developed a comprehensive database, CircAge, which encompasses 756 aging-related samples from 7 species and 24 tissue types. Through high-throughput sequencing, we also generated 47 new tissue samples from mice and rhesus monkeys. By integrating predictions from multiple bioinformatics tools, we identified over 529,856 unique circRNAs. Our data analysis revealed a general increase in circRNA expression levels with age, with approximately 23% of circRNAs demonstrating sequence conservation across species. The CircAge database systematically predicts potential interactions between circRNAs, microRNAs (miRNAs), and RNA-binding proteins (RBPs), and assesses the coding potential of circRNAs. This resource lays a foundation for elucidating the regulatory mechanisms of circRNAs in aging. As a comprehensive repository of aging-associated circRNAs, CircAge will significantly accelerate research in this field, facilitating the discovery of novel biomarkers and therapeutic targets for aging biology and supporting the development of diagnostic and therapeutic strategies for aging and age-related diseases. CircAge is publicly available at https://circage.kiz.ac.cn.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Genetic Evolution & Animal Models, Key Laboratory of Healthy Aging Research of Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650201, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Biodiversity Data Center of Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650201, China.
- Yunnan Key Laboratory of Biodiversity Information, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650201, China.
- Laboratory Animal Center, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650201, China.
- National Resource Center for Non-Human Primates, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming 650201, China.
ORCID-Profile: Xin Dong, Zhen Zhou, Yanan Wang, Ayesha Nisar, Shaoyan Pu, Longbao Lv, Yijiang Li, Xuemei Lu, Yonghan He
Zitieren
APA
Dong, X., Zhou, Z., Wang, Y., Nisar, A., Pu, S., Lv, L., Li, Y., Lu, X., & He, Y. (2025). CircAge: A Comprehensive Resource for Aging-associated Circular RNAs Across Species and Tissues. Genomics, Proteomics & Bioinformatics. https://doi.org/10.1093/gpbjnl/qzaf044
Vancouver
Dong X, Zhou Z, Wang Y, Nisar A, Pu S, Lv L, et al. CircAge: A Comprehensive Resource for Aging-associated Circular RNAs Across Species and Tissues. Genomics, Proteomics & Bioinformatics. 2025. doi:10.1093/gpbjnl/qzaf044
BibTeX
@article{Dong2025,
author = {Dong, Xin and Zhou, Zhen and Wang, Yanan and Nisar, Ayesha and Pu, Shaoyan and Lv, Longbao and Li, Yijiang and Lu, Xuemei and He, Yonghan},
title = {CircAge: A Comprehensive Resource for Aging-associated Circular RNAs Across Species and Tissues},
journal = {Genomics, Proteomics & Bioinformatics},
year = {2025},
doi = {10.1093/gpbjnl/qzaf044}
}
EUVIMED